An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY)

NCT02451839 · clinicaltrials.gov ↗
COMPLETED
Status
168
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AbbVie